Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioindustria Laboratorio Italiano Medicinali S.p.A. (Bioindustria LIM) is a prominent Italian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Established in 1947 and headquartered in Novi Ligure, the company has built a global reputation for its expertise in the synthesis of corticosteroids and synthetic hormones. Operating as a Contract Development and Manufacturing Organization (CDMO), it provides a full range of services from process R&D and pilot plant scale-up to high-volume industrial production. The company's facilities are cGMP compliant and have been successfully inspected by major regulatory agencies, including the FDA and AIFA. Bioindustria LIM serves an international clientele, delivering high-quality chemical entities used in treating inflammatory and endocrine disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioindustria Laboratorio Italiano Medicinali.